- Home
- ACLS vs CERT Comparison
ACLS vs CERT Comparison
Compare ACLS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- CERT
- Stock Information
- Founded
- ACLS 1995
- CERT 2008
- Country
- ACLS United States
- CERT United States
- Employees
- ACLS N/A
- CERT N/A
- Industry
- ACLS Industrial Machinery/Components
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ACLS Technology
- CERT Technology
- Exchange
- ACLS Nasdaq
- CERT Nasdaq
- Market Cap
- ACLS 2.3B
- CERT 1.9B
- IPO Year
- ACLS 2000
- CERT 2020
- Fundamental
- Price
- ACLS $71.46
- CERT $11.01
- Analyst Decision
- ACLS Buy
- CERT Buy
- Analyst Count
- ACLS 7
- CERT 7
- Target Price
- ACLS $138.00
- CERT $15.17
- AVG Volume (30 Days)
- ACLS 505.1K
- CERT 1.8M
- Earning Date
- ACLS 07-30-2025
- CERT 08-06-2025
- Dividend Yield
- ACLS N/A
- CERT N/A
- EPS Growth
- ACLS N/A
- CERT N/A
- EPS
- ACLS 5.46
- CERT N/A
- Revenue
- ACLS $958,056,000.00
- CERT $394,498,000.00
- Revenue This Year
- ACLS N/A
- CERT $11.52
- Revenue Next Year
- ACLS $7.62
- CERT $8.74
- P/E Ratio
- ACLS $13.09
- CERT N/A
- Revenue Growth
- ACLS N/A
- CERT 9.37
- 52 Week Low
- ACLS $40.40
- CERT $8.64
- 52 Week High
- ACLS $152.65
- CERT $16.93
- Technical
- Relative Strength Index (RSI)
- ACLS 55.58
- CERT 46.88
- Support Level
- ACLS $70.64
- CERT $10.83
- Resistance Level
- ACLS $76.80
- CERT $11.71
- Average True Range (ATR)
- ACLS 2.53
- CERT 0.44
- MACD
- ACLS -0.15
- CERT 0.05
- Stochastic Oscillator
- ACLS 43.31
- CERT 52.52
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.